Outcomes of Childhood Hemangiomas Treated with the Pulsed-Dye Laser with Dynamic Cooling

Rizzo, Carina; Brightman, Lori; Chapas, Anne; Hale, Elizabeth K.; Cantatore-Francis, Julie L.; Bernstein, Leonard; Geronemus, Roy G.

doi:10.1111/j.1524-4725.2009.01356.x

Cited by 78 publications

(87 citation statements)

References 16 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…151 The controversy over laser use was recently rekindled by a study that showed an advantage to early laser management. 282 Although small IHs may be treated without sedation, children with larger lesions often require general anesthesia. Recent data suggest that early exposure to general anesthesia may have a negative effect on learning and behavior.…”

Section: Laser Therapy For Ihmentioning

confidence: 99%

Diagnosis and Management of Infantile Hemangioma

Darrow¹,

Mancini²,

Nopper³

et al. 2015

Pediatrics

211

290

View full text Add to dashboard Cite

Infantile hemangiomas (IHs) are the most common tumors of childhood. Unlike other tumors, they have the unique ability to involute after proliferation, often leading primary care providers to assume they will resolve without intervention or consequence. Unfortunately, a subset of IHs rapidly develop complications, resulting in pain, functional impairment, or permanent disfigurement. As a result, the primary clinician has the task of determining which lesions require early consultation with a specialist. Although several recent reviews have been published, this clinical report is the first based on input from individuals representing the many specialties involved in the treatment of IH. Its purpose is to update the pediatric community regarding recent discoveries in IH pathogenesis, treatment, and clinical associations and to provide a basis for clinical decision-making in the management of IH.

show abstract

Section: Laser Therapy For Ihmentioning

confidence: 99%

Diagnosis and Management of Infantile Hemangioma

Darrow¹,

Mancini²,

Nopper³

et al. 2015

Pediatrics

211

290

View full text Add to dashboard Cite

show abstract

“…Specifically, a total number of 90 infants were included with a median age of 3.0 months with a total number of 105 haemangiomas, and were treated doi:10.18282/jsd.v2.it1.109 using this particular laser device. The results showed that complete or near-complete clearance was achieved for 81% of the haemangiomas in terms of colour and 64% in terms of thickness [21] . Similar results were also found by a study conducted in Korea, in which a total number of 239 patients with skin types II-V participated and of whom, 37 patients had haemangiomas, and the same variable-pulse PDL method was used.…”

Section: Cutaneous Haemangiomasmentioning

confidence: 90%

Management of vascular lesions using advanced laser technology

Tzermias¹,

Eleftheriadi²,

Gkiouzepaki³

2017

J Surg Dermatol

View full text Add to dashboard Cite

Abstract:One of the most widely used cutaneous applications of Light Amplification by Stimulated Emission of Radiation (laser) concerns the treatment of vascular lesions. During the past two decades, very significant advances in the application of laser technology in dermatology have occurred, with selective photothermolysis being the most important. This review focuses on the application of modern laser devices (Pulsed Dye Laser, or PDL; potassium titanyl phosphate laser, or KTP; diode laser; and neodymium-doped yttrium-aluminium-garnet laser, or Nd:YAG), as well as the combination of laser and photodynamic therapy (PDT) for the treatment of vascular lesions. In lar, both congenital (haemangiomas and port-wine stains) and acquired vascular lesions (facial and leg telangiectasias, rosacea, Poikiloderma of Civatte, spider angioma, pyogenic granuloma, and venous lakes) are discussed. The review of many recent research studies demonstrates that modern applications of lasers in dermatology constitute the finest method for the treatment of vascular lesions, combining the advantages of invasive therapy with the security offered by non-invasive therapy, while in certain cases they are the single and only choice for the treatment of these lesions.Keywords: Va scular lesions; laser; PDL; Nd:YAG; PDT Citation: Tzermias C, Eleftheriadi A, Gkiouzepaki I. Management of vascular lesions using advanced laser technology.

show abstract

“…Two studies, a level II prospective RCT 80 and a level V retrospective review, 81 have shown increased efficacy in the treatment of IHs with these lasers. Despite the availability of newer, more effective lasers, the literature still supports the use of these instruments mainly for the treatment of superficial rather than deep IHs.…”

Section: Pulsed Dye Laser Therapymentioning

confidence: 98%

“…75 The PDL has been used and studied for more than 30 years as an option for treatment of IHs, and, as a result, there is substantial level III-V evidence in the form of various case reports, retrospective reviews, and small, nonrandomized prospective studies supporting its efficacy in the literature. [76][77][78][79][80][81][82][83] In 2002, the first level III evidence comparing PDL therapy to observation in the treatment of IHs was performed by Batta and colleagues 84 and raised significant doubt surrounding its efficacy. The investigators' analysis revealed no benefit in the number of children whose lesions showed complete clearance or minimal residual signs at 1 year in the PDL versus observation group.…”

Section: Pulsed Dye Laser Therapymentioning

confidence: 98%